Skip to main content
. 2018 May 18;9(38):25225–25243. doi: 10.18632/oncotarget.25396

Figure 2. Two-year disease-free survival rate of patients with OSCC.

Figure 2

Relationships between 2-year disease-free survival and (A) TRKB overexpression, (B) BDNF overexpression, (C) TRKB/BDNF overexpression, and (D) tumor differentiation were analyzed using the Kaplan–Meier method. *P < 0.05.